How ENDOLLS Was Designed Around the Iron Paradox in Endometriosis

Watch the original video on TikTok

Full transcript of the original video, lightly edited for readability.

I've been getting this question a lot lately. If endometriosis creates this iron recycling problem you've been talking about, how exactly does the ENDOLLS, Endometriosis and Adenomyosis Supplement help? I love this question, but first and foremost, I think there's a misconception about what endorphins was actually designed to do. You see, it was never designed for a singular purpose. It wasn't designed to bypass ephedrine. It wasn't designed to directly increase for important. Instead, it was designed around a completely different concept. Systems biology, stochastic processes, and network topology.

Now, let's take a look into how that applies to the Iron Paradox. Let's quickly summarize the previous video. One of the biggest discoveries we've been working on is something we call the Iron Paradox. Systemically, women with endometriosis and adenomyosis often become profoundly iron deficient. They're exhausted, they're dizzy, they're short of breath. Their muscles feel weak, their hair begins shedding. Their bodies feel like they're running on empty. But locally, inside the lesions, the exact opposite may be happening. Repeated internal bleeding releases enormous amounts of hemoglobin, hem and free iron.

Macrophages rush in to clean it up, but eventually become overloaded with iron themselves. At the same time, inflammatory cytokines like IL-6 tell the liver to produce hepcidin. Hepcidin destroys ferroportin, the only known iron export protein. Now the exit doors close. Iron can't leave macrophages. Iron can't leave intestinal cells. Iron becomes trapped. So now you have a woman whose bloodstream is starving for usable iron. While the disease environment is literally drowning in it. That's the iron paradox. Now, here's where ENDOLLS comes in.

Instead of asking, how do we add more iron? We asked, how do we change the biological network that's creating the paradox in the first place? Because biology doesn't operate through one pathway. It operates through networks. Step 1. Break the Inflammatory Attractor state. One of the central ideas in our systems biology model is that endometriosis isn't simply an inflammatory disease. It's trapped inside what systems biologists call a pathological attractor basin. Think of it like a valley. Once the disease falls into that valley, every pathway reinforces every other pathway.

Inflammation drives oxidative stress, oxidative stress drives fibrosis. Fibrosis drives immune dysfunction. Immune dysfunction drives more inflammation. The disease becomes self perpetuating. This is a stable but maladaptive biological equilibrium maintained by chronic cytokine signaling, oxidative stress, and persistent receptor activation. So instead of trying to shut down one pathway, ENDOLLS was conceptually designed to slowly bias multiple signaling networks back toward homeostasis over time. Not through brute force, through network modulation. Now moving on to step 2. Reduce the inflammatory signals that keep Hep C in elevated.

One of the biggest drivers of hep C is IL-6. If IL-6 remains elevated, Hep C remains elevated. If hepidin remains elevated, ferroportin continues being degraded. If ferroportin disappears, iron stays trapped. This is where salicylate from white Willow becomes incredibly interesting. Salicylates activate AMPK activated AMPK suppresses NF-kappa B. When NF-kappa B activity falls, IL-6 production decreases. As IL-6 decreases, our model proposes that hepsin signalling may also decrease. That allows newly synthesized ferrophortin to remain on macrophages and intestinal cells instead of being continuously destroyed.

In simple terms, the exit doors begin reopening. Not because we're forcing them open, but because we're removing one of the signals telling the body to keep them shut. Now, step 3. Reprogram the macrophages. Macrophages are supposed to recycle iron. That's one of their jobs. But inside endometriosis, they become overwhelmed. Instead of recycling iron, they become storage cells filled with hemo siderin. They remain inflammatory. They continue releasing IL-6 TNF-alpha, C 0 x two, and they help maintain the disease. This is where tiloroside from Rosa Canina becomes fascinating, as tiloroside has been seen to suppress HIF-1 alpha, shifting macrophages away from glycolysis and away from the inflammatory M1 phenotype toward the tissue repairing M2 phenotype.

Instead of remaining trapped in perpetual inflammation, the macrophage begins behaving more like a healing cell again. As that happens, the inflammatory environment surrounding iron begins changing. Not because iron was added, but because the immune system is functioning differently. Step 4 collapse the lesions antioxidant shield. This is probably my favourite part of the entire concept. One of the biggest questions in endometriosis is this. If lesions are surrounded By iron. Why don't they die? Iron plus hydrogen peroxide should generate hydroxyl radicals. Those radicals should cause massive lipid peroxidation that should trigger ferroptosis, an iron dependent form of programmed cell death.

But the lesions survive. Why? Because of something we call selective redox survival. The lesion protects itself while allowing enough oxidative stress to remain active to drive inflammation, angiogenesis, fibrosis, and survival. It lives inside an environment that should kill it because it builds an antioxidant shield around itself. That shield depends heavily on the SLC7A11 glutathione and GPX4 pathway. Now, here's where rodeola becomes incredibly interesting. Solid side appears to behave differently depending on the tissue it's in. In healthy tissues, it supports NRF2 signalling, helping healthy cells defend themselves against oxidative injury.

But inside rapidly proliferating pathological cells, published mechanistic studies suggest salidroside can inhibit the SLC7A11 GSH, GPX4 survival axis while also suppressing AKT mTOR. Signaling. If that same biology applies to endometriotic tissue, the lesion loses its antioxidant armor. Now it's sitting inside an iron rich environment without the Protection it previously relied on. The environment it adapted to may now become the environment that destroys it. Now onto step 5. Attack the same survival pathway from another direction. This is why ENDOLLS doesn't rely on one ingredient.

DIM provides another theoretical angle. DIM activates the aryl Hydrocarbon receptor. Published mechanistic work suggests this can suppress GPX4 and SLC7A11 while simultaneously lowering glutathione inside pathological cells. Again, the target isn't healthy tissue. The target is the lesion's selective redox survival mechanism. Now you have two compounds approaching the same survival network from different directions. That's systems biology, not redundancy synergy. Step 6. Turn the lesion's own iron against itself. Tiloricide doesn't just help macrophages. It may also induce ferritinophagy inside pathological cells. Ferritin is where cells store iron safely.

Ferritinophagy breaks that storage apart, releasing iron back into the cell. Normally, that sounds dangerous. But inside a lesion that simultaneously losing GPX4 Protection, that sudden increase in free iron may dramatically amplify lipid peroxidation. In other words, the lesion's own stored iron becomes part of the mechanism driving ferroptosis. It weaponizes the disease's own biology against itself. Now, step 7. Clear the iron before it becomes toxic. Iron isn't only dangerous inside cells, it's dangerous outside them, too. After repeated bleeding, the pelvis becomes filled with damaged red blood cells.

Free hemoglobin, hem, and iron. Our model incorporates high molecular weight beta glucan for this reason, not because it's simply immune boosting. High molecular weight beta glucans cluster dectin 1 receptors, forming what researchers call a phagocytic synapse that dramatically improves macrophage phagocytosis. The idea is straightforward. Clear the damaged blood, clear the extracellular hem. Clear the iron before it continues fueling oxidative stress. You're improving Clean up instead of allowing debris to accumulate cycle after cycle. Step 8. Restore neurological homeostasis. Finally, there's valerian.

People assume valerian is simply for sleep. That's not why it's in ENDOLLS. Valeric acid is a positive allosteric modulator of specific G A B A. Receptors. It increases the probability those Chloride channels remain open. That lowers neuronal excitability. Why does that matter? Because chronic inflammation, iron deficiency, and persistent pelvic pain all contribute to central sensitization. The nervous system becomes hyper excitable. Everything hurts more. Fatigue worsens. Restless legs worsen. Pain amplification increases. Valeric acid wasn't included simply to make someone sleepy. It was theoretically included to help shift the pain network back toward neurological homeostasis over time.

Now, let's step back and look at the entire system. ENDOLLS doesn't fix iron because it contains iron. Its goal is to restore iron homeostasis because it was designed to target the biological network, creating the paradox. Reduce chronic inflammatory signaling. Reduce IL-6. Relieve hepidin pressure. Allow ferropotent to stabilize. Improve iron export from macrophages and enterocytes. Reprogram macrophages toward tissue repair. Improve clearance of HEM and damaged red blood cells. Collapse the lesion's selective redox survival mechanisms. Turn the lesion's own iron against itself.

Reduce central sensitization. Move the biological network out of its pathological attractor state and gradually back toward homeostasis. Now, I wanna be very clear. This is our conceptual model and understanding of molecular mechanisms of action. It is based on systems biology. Published mechanistic Studies and on individual bioactive compounds and our integrated understanding of iron homeostasis in endometriosis and adenomyosis. This framework explains why the formula was built the way that it was. And this is, mind you, a small portion of the formulation's ultimate goal.

There's more that we try to focus on because our focus is not on the singular ingredient. It's not around one receptor or one symptom, but around the interconnected biological network. Because I don't believe in the endometriosis is a one pathway disease. I believe it's a systems biology disease. And if that's true, then restoring health isn't about overwhelming one target. It's about gradually nudging the entire network back towards a state that it was always designed to live in.